Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07507422 · ClinicalTrials.gov registry record
Post Market Evaluation of Real World Outcomes and Durability to Support Implantable Inceptiv™ Spinal Cord Stimulation Therapy
A clinical trial, sponsored by Medtronic.
- Recruiting
- Registry status
- 970
- Enrollment target
NCT07507422 is a clinical trial that is actively recruiting participants, run by Medtronic. The registered enrollment target is 970 participants.
The verdict
NCT07507422 is actively recruiting participants, sponsored by Medtronic.
- RECRUITING
- Registry status
- 970 participants
- Enrollment target
Study Summary
The PERSIST study is being conducted within Medtronic's active post-market surveillance platform, the Product Surveillance Registry (PSR). The purpose of PERSIST is to generate long-term evidence for the Inceptiv™ Spinal Cord Stimulation therapy.
Interventions
- DEVICE Commercially available Inceptiv™ neurostimulation systems
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 970 participants |
| Start Date | 2026-04-17 |
| Est. Completion | 2034-01-11 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07507422
The ClinicalTrials.gov registry entry for NCT07507422 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 970 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Medtronic, which has 30 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Commercially available Inceptiv™ neurostimulation systems is the first listed.
NCT07507422 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07507422 about?
NCT07507422 is a clinical study titled "Post Market Evaluation of Real World Outcomes and Durability to Support Implantable Inceptiv™ Spinal Cord Stimulation Therapy". The PERSIST study is being conducted within Medtronic's active post-market surveillance platform, the Product Surveillance Registry (PSR). The purpose of PERSIST is to generate long-term evidence for the Inceptiv™ Spinal Cord Stimulation therapy.
What is the current status of trial NCT07507422?
This trial is currently recruiting. The enrollment target is 970 participants. The study started on 2026-04-17. Estimated completion is 2034-01-11.
What interventions are being tested in trial NCT07507422?
The interventions under investigation include: Commercially available Inceptiv™ neurostimulation systems (DEVICE).
Who is sponsoring clinical trial NCT07507422?
This trial is sponsored by Medtronic, which has 30 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.